scholarly article | Q13442814 |
P2093 | author name string | Amine Kamen | |
Héla Kallel | |||
Khaled Trabelsi | |||
P2860 | cites work | Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome | Q33415661 |
A rapid method for titrating baculovirus stocks using the Sf-9 Easy Titer cell line | Q33512096 | ||
Hepatitis E vaccine | Q37278231 | ||
Hepatitis E: Historical, contemporary and future perspectives | Q37825651 | ||
Production of adeno-associated viral vectors in insect cells using triple infection: optimization of baculovirus concentration ratios. | Q40235892 | ||
Quantitation of baculovirus particles by flow cytometry | Q40701980 | ||
Titration of non-occluded baculovirus using a cell viability assay | Q44338255 | ||
Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial | Q45189946 | ||
P433 | issue | 24 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatitis E | Q326643 |
vector-borne disease | Q2083837 | ||
hepatitis E virus | Q5731737 | ||
P1104 | number of pages | 4 | |
P304 | page(s) | 2808-2811 | |
P577 | publication date | 2014-02-26 | |
P1433 | published in | Vaccine | Q7907941 |
P1476 | title | Development of a vectored vaccine against hepatitis E virus | |
P478 | volume | 32 |
Q56588500 | Development of new hepatitis E vaccines |
Q54254955 | Hepatitis E: Update on Prevention and Control. |
Q47159881 | Public health risks associated with hepatitis E virus (HEV) as a food‐borne pathogen |
Q36756695 | Serotype-specific Binding Properties and Nanoparticle Characteristics Contribute to the Immunogenicity of rAAV1 Vectors |